Skip to content
healthcare.dev

CINVANTI

NDC 47426-201, aprepitant, injection, emulsion, from Heron Therapeutics, Inc..

Product NDC
47426-201
Status
Listed
Labeler
Heron Therapeutics, Inc.
Dosage form
INJECTION, EMULSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209296
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47426-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • APREPITANT130 mg/18mL

Pharmacologic classes

Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
47426-201-01474260201011 VIAL, GLASS in 1 CARTON (47426-201-01) / 18 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4c218d3a-a508-4abc-9ed8-a6e8e191d1b4
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=47426-201

Use it

Look up 47426-201 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47426-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47426-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.